19.01
Enliven Therapeutics Inc 주식(ELVN)의 최신 뉴스
Enliven Therapeutics (NASDAQ:ELVN) Stock Price Down 12.3%Here's What Happened - MarketBeat
Enliven Therapeutics Inc. stock daily chart insights2025 Bull vs Bear & Daily Market Momentum Tracking - newser.com
What analyst consensus says on Enliven Therapeutics Inc. stock2025 AllTime Highs & Weekly High Return Opportunities - newser.com
Enliven Therapeutics showcases promising results for ELVN-001 in CML trial - Traders Union
Enliven (NASDAQ: ELVN) presents ELVN-001 CML data at ASH 2025 with >1 log transcript declines - Stock Titan
Is Enliven Therapeutics Inc. stock positioned well for digital economyJuly 2025 PreEarnings & Fast Entry High Yield Tips - newser.com
Real time breakdown of Enliven Therapeutics Inc. stock performanceJuly 2025 Fed Impact & Free Long-Term Investment Growth Plans - newser.com
Can Enliven Therapeutics Inc. stock deliver strong Q4 earnings2025 Market Overview & Long-Term Growth Stock Strategies - newser.com
Is Enliven Therapeutics Inc. stock a contrarian buy2025 Short Interest & Fast Moving Trade Plans - newser.com
Using data filters to optimize entry into Enliven Therapeutics Inc.Oil Prices & Community Supported Trade Ideas - newser.com
Applying sector rotation models to Enliven Therapeutics Inc.Weekly Profit Summary & Daily Risk Controlled Trade Plans - newser.com
Why Enliven Therapeutics Inc. stock appeals to dividend seekers2025 Short Interest & Growth Oriented Trading Recommendations - newser.com
Enliven Therapeutics Inc. recovery potential after sell offExit Point & Risk Controlled Swing Alerts - newser.com
Is Enliven Therapeutics Inc. stock a safe haven assetWeekly Earnings Recap & Fast Entry Momentum Alerts - newser.com
Is Enliven Therapeutics Inc. stock cheap compared to fundamentalsInsider Selling & Free Expert Verified Stock Movement Alerts - newser.com
Automated trading signals detected on Enliven Therapeutics Inc.Portfolio Value Report & Safe Swing Trade Setups - newser.com
Is Enliven Therapeutics Inc a good long term investmentFederal Reserve Announcements & Build Wealth With Zero-Cost Tools - earlytimes.in
Enliven Therapeutics (ELVN): Evaluating Valuation Following Phase 1 ELVN-001 Update for Resistant Leukemia - Sahm
자본화:
|
볼륨(24시간):